Adjuvant concurrent chemoradiation using intensity-modulated radiotherapy and simultaneous integrated boost for resected high-risk adenocarcinoma of the distal esophagus and gastro-esophageal junction

PURPOSE: Multimodality therapy leads to improved outcomes for adenocarcinoma of the distal esophagus and gastroesophageal junction (GEJ) over surgery alone. At our institution, adjuvant chemoradiation (chemoRT) using IMRT and SIB is standard of care for resected high-risk disease. In this study, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Yaremko, Brian P, Palma, David A, Erickson, Abigail L, Pierce, Gregory, Malthaner, Richard A, Inculet, Richard I, Dar, A Rashid, Rodrigues, George B, Yu, Edward
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3599957/
https://www.ncbi.nlm.nih.gov/pubmed/23398690
http://dx.doi.org/10.1186/1748-717X-8-33

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3599957/
https://www.ncbi.nlm.nih.gov/pubmed/23398690
http://dx.doi.org/10.1186/1748-717X-8-33

Ejemplares similares